Biohaven Ltd. (BHVN) Institutional Ownership

Ownership Summary

Biohaven Ltd. (NYSE:BHVN) showed up in the 13F filings of 265 institutional investors as of December 2025.

• They owned 110.2% of outstanding stock in December 2025, up from 82.0% the prior quarter.
• They increased total shares held in Biohaven by 54.57% from last quarter, and the number of investors in BHVN increased 4.33% annually.
• Among the 265 funds, 183 bought more Biohaven shares, 53 sold down, and 29 held their ground.
• Combined, these investors held 116.61Mn shares in BHVN for December 2025, up by 41.17Mn shares quarter on quarter, and up 22.59Mn shares year over year.
• As of December 31, 2025, the biggest holder of Biohaven is Janus Henderson Group Plc at 35.07Mn shares, representing 33.14% of shares outstanding.
• The most significant purchases of BHVN for the quarter ending December 2025 came from Janus Henderson Group Plc (33.66Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.28Mn), PRICE T ROWE ASSOCIATES INC /MD/ (2.22Mn), BlackRock, Inc. (1.77Mn), Cormorant Asset Management, LP (1.75Mn).
• Top sellers of BHVN stock for the quarter ending December 2025 included Goldman Sachs Group Inc (1.41Mn), Bank Of America Corp /De/ (1.03Mn), AMERICAN CENTURY COMPANIES INC (674.22K), Walleye Capital LLC (650.95K), JANE STREET GROUP, LLC (611.07K).
• Per Business Quant data, the top 10 holders of Biohaven for the quarter ending December 2025 are Janus Henderson Group Plc (35.07Mn), BlackRock, Inc. (11.22Mn), SUVRETTA CAPITAL MANAGEMENT, LLC (10.29Mn), Stifel Financial Corp (9.94Mn), State Street Corp (6.62Mn), INFINITUM ASSET MANAGEMENT, LLC (6.25Mn), TCG Crossover Management, LLC (4.63Mn), Royalty Pharma Sub-Manager, LLC (2.94Mn), D. E. Shaw & Co., Inc. (2.85Mn), GEODE CAPITAL MANAGEMENT, LLC (2.77Mn).